Positive Airway Pressure Device Segment of the Global Respiratory Devices Market to Grow at an Outstanding CAGR during the Forecast Period

The report provides detailed analysis of the current and emerging trends of respiratory devices market. The market size has been provided for product type and application segments. Based on product type, the market is segmented into therapeutic devices, respiratory disposables and monitoring and diagnostic devices. In terms of application the market is segmented into COPD, asthma, obstructive sleep apnea, respiratory distress, cystic fibrosis and pneumonia. The report provides forecasts for revenue (US$ Mn) and volume (No. of Units) of the products from 2017–2025. The Respiratory Devices Market is projected to reach US$ 22.1 Bn in 2025 at a CAGR of 6.1% from 2017 to 2025.

According to product type, the global respiratory devices market is broadly segmented into therapeutic devices, respiratory disposables and monitoring and diagnostic devices. The therapeutic devices are used in treating patients suffering from respiratory distress. Therapeutic devices are further segmented into humidifiers, nebulizers, positive airway pressure, oxygen concentrators, reusable resuscitators, ventilators, inhalers and others. The other segment masks, nitric oxide delivery units, oxygen hoods. In the therapeutic segment the positive airway pressure device segment is expected to grow at an outstanding CAGR of 7.7% during the forecast period. Positive Airway Pressure Devices are used treating sleep apnea patients. These devices are of two types continuous positive airway pressure (CPAP) devices and bi – level positive airway pressure devices. CPAP is used for treating breathing problems such as sleep apnea, respiratory distress and bonchopulmonary dysplasia. Oxygen concentrators and ventilators are also highly contributing segments in terms of revenue for the growth of the therapeutic devices segment.

Inquire for a Sample Copy of Report – http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=28073

In respiratory disposables segment, the tracheostomy tubes and reusable resuscitators contribute a majorly for the growth of the segment. Resuscitator is used for treating a person who is not able to breathe normally or whose breathing is disrupted. Since reusable resuscitators are prone to infection, there has been a rise in trend of companies introducing disposable resuscitators to eliminate the risk of contamination. Tracheostomy tube is a curved tube that is inserted in the windpipe. Tracheostomy is performed in critical conditions such as obstructed upper airway for the safe delivery of oxygen to lungs, and to clean the airway system. A typical tracheostomy tube consists of cuffed tube with a disposable inner cannula. The advantages of using disposables will drive the growth of the market during the forecast period.

The diagnostic and monitoring devices market is driven by the growth of polysomnography devices. Polysomnography device is used in the study of sleep and acts a diagnostic tool in management of sleep medicine. This device monitors many boy functions including brain, eye movements, muscle activity and heart rhythm during sleep. This is followed by capnographs and spirometers. Capnographs are used during operative procedures and intensive care units to monitor the concentration or level of carbon dioxide in exhaled respiratory gases. The market for capnographs is growing by leaps and bounds due to the increased need for patient monitoring outside operating rooms. As the device measures level of carbon dioxide in exhaled respiratory gases, it helps to gather useful information with respect to ventilation and perfusion of the patient. Spirometer is a device which is used by physicians for measuring and assessing lung functions. It is also used for the diagnosis of respiratory problems such as bronchitis, asthma, emphysema, and severity of the lung disease along with monitoring treatment effectiveness.

The respiratory products market is highly driven by the rising incidence of diseases such as COPD, asthma and other respiratory disorders and also by innovation in medical devices, increasing awareness regarding home care respiratory devices, strategic alliances including technology transfer and building strong distribution network, increasing healthcare infrastructure with rising government investment in healthcare in developing nations. All these factors will drive the growth of all respiratory devices during the forecast period.

In terms of application, the global respiratory devices market is segmented into COPD, asthma, obstructive respiratory syndrome, respiratory distress, cystic fibrosis and pneumonia. Chronic Obstructive Pulmonary Diseases (COPD) is a progressive condition of lung disease including emphysema, chronic bronchitis, asthma and bronchiectasis. The condition is characterized by increasing breathlessness. According to WHO, in 2015, there were 3 million deaths globally due to COPD, which accounts for 5% of all global deaths in 2015. Among this more than 90% deaths occur in low and middle income groups. According to The Global Asthma Report, by 2014 asthma has affected to approximately 334 million individuals of all age globally. Increasing prevalence of cystic fibrosis in developed countries and undiagnosed cystic fibrosis in developing countries is one of the factor which accelerate the growth of the market during the forecast period. Cystic fibrosis is a genetic condition which affects lungs, pancreas, liver, kidney and intestine. With progression of the diseases the effects of cystic fibrosis are difficulty in breathing, frequent lung infection and coughing with mucous. In the U.S. there are approximately 1,000 new cases diagnosed with cystic fibrosis every year, in Europe there the incidence of cystic fibrosis is 1 in 2000 – 3000 newborns. Whereas in the Asia Pacific and other regions the condition is highly undiagnosed. Along with these diseases, continuous rising prevalence of pneumonia is also an important factor driving the growth of the market.

Major players operating in the global respiratory devices market are Chart Industries, Inc., Koninklijke Philips N.V., Resmed Inc., GE Healthcare, Becton, Dickinson and Company, Teleflex Incorporated, Medtronic plc., Smiths Medical, Drägerwerk AG & Co. KGaA,
Fisher & Paykel Healthcare Limited, Getinge AB and others.

Read Report with Complete TOC – http://www.transparencymarketresearch.com/respiratory-devices-market.html

Name: Rohit Bhisey
Organization: Transparency Market Research

ReleaseID: 8130